Paralytic myopathy - A leading clinical presentation for primary aldosteronism in Taiwan

被引:24
|
作者
Huang, YY [1 ]
Hsu, BRS [1 ]
Tsai, JS [1 ]
机构
[1] CHANG GUNG MEM HOSP, CHANG GUNG MED CTR, DIV ENDOCRINOL & METAB, TAOYUAN, TAIWAN
来源
关键词
D O I
10.1210/jc.81.11.4038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Between 1982 and 1995, 43 cases of primary aldosteronism, 36 cases of adenoma, and 7 cases of hyperplasia were treated in Chang Gung Medical Center. Twenty-one of these (49%) presented with muscular paralysis as an initial symptom (categorized as the paralytic group). Seven patients in the paralytic group (33%) had extra-limb muscle involvement. Six of them presented with bulbar palsy and one patient had a peripheral-type facial palsy. The serum potassium levels in the paralytic group were significantly lower than those of the nonparalytic group (1.8 +/- 0.3 vs. 2.3 +/- 0.4 mmol/L, P = 0.0001). There were no significant differences in blood pressure or the serum aldosterone level between the two groups. Provocative factors such as a high carbohydrate diet, vigorous exercise, or seasonal variation did not appear to play a significant role in inducing the symptoms. Paralytic myopathy appears to be more common in Oriental people. The symptom is rarely reported among western populations. Primary aldosteronism should be considered in patients presenting with neuromuscular weakness associated with hypokalemia, regardless of the degree of hypertension.
引用
收藏
页码:4038 / 4041
页数:4
相关论文
共 50 条
  • [21] HYPOKALEMIC MYOPATHY ASSOCIATED WITH PRIMARY ALDOSTERONISM AND GLYCYRRHIZINE-INDUCED PSEUDOALDOSTERONISM
    ISHIKAWA, S
    SAITO, T
    OKADA, K
    ATSUMI, T
    KUZUYA, T
    ENDOCRINOLOGIA JAPONICA, 1985, 32 (06): : 793 - 802
  • [22] Primary Aldosteronism: Does Underlying Pathology Impact Clinical Presentation and Outcomes Following Unilateral Adrenalectomy?
    Omair A. Shariq
    Kabir Mehta
    Geoffrey B. Thompson
    Melanie L. Lyden
    David R. Farley
    Irina Bancos
    Benzon M. Dy
    William F. Young
    Travis J. McKenzie
    World Journal of Surgery, 2019, 43 : 2469 - 2476
  • [23] Primary Aldosteronism: Does Underlying Pathology Impact Clinical Presentation and Outcomes Following Unilateral Adrenalectomy?
    Shariq, Omair A.
    Mehta, Kabir
    Thompson, Geoffrey B.
    Lyden, Melanie L.
    Farley, David R.
    Bancos, Irina
    Dy, Benzon M.
    Young, William F., Jr.
    McKenzie, Travis J.
    WORLD JOURNAL OF SURGERY, 2019, 43 (10) : 2469 - 2476
  • [24] Clinical Management of Primary Aldosteronism: An Update
    Rossi, Gian Paolo
    Rossi, Federico Bernardo
    Guarnieri, Chiara
    Rossitto, Giacomo
    Seccia, Teresa M.
    HYPERTENSION, 2024, 81 (09) : 1845 - 1856
  • [25] PRIMARY ALDOSTERONISM - A NEW CLINICAL ENTITY
    CONN, JW
    LOUIS, LH
    TRANSACTIONS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1955, 68 : 215 - 233
  • [26] Changes in the clinical manifestations of primary aldosteronism
    Kim, Sun Hwa
    Ahn, Jae Hee
    Hong, Ho Cheol
    Choi, Hae Yoon
    Kim, Yoon Jung
    Kim, Nam Hoon
    Yoo, Hye Jin
    Kim, Hee Young
    Seo, Ji A.
    Kim, Nan Hee
    Kim, Sin Gon
    Choi, Kyung Mook
    Baik, Sei Hyun
    Choi, Dong Seop
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2014, 29 (02): : 217 - 225
  • [27] PRIMARY ALDOSTERONISM, A NEW CLINICAL ENTITY
    CONN, JW
    LOUIS, LH
    ANNALS OF INTERNAL MEDICINE, 1956, 44 (01) : 1 - 15
  • [28] Clinical Analysis of Primary Aldosteronism with Hypertension
    Liang, Shangyan
    Yang, Xubin
    Luo, Sihui
    Wang, Yina
    Yin, Qiongli
    Ye, Xiaoming
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C207 - C207
  • [29] Clinical classification and genotype of primary aldosteronism
    Goo, J.
    Gong, Y.
    JOURNAL OF HYPERTENSION, 2008, 26 : S73 - S73
  • [30] THE CHANGING CLINICAL SPECTRUM OF PRIMARY ALDOSTERONISM
    BRAVO, EL
    TARAZI, RC
    DUSTAN, HP
    FOUAD, FM
    TEXTOR, SC
    GIFFORD, RW
    VIDT, DG
    AMERICAN JOURNAL OF MEDICINE, 1983, 74 (04): : 641 - 651